Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Krischer

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Seminars in Hematology|July 1, 1992
Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulinJ Krischer, G Elfenbein, R Babington, et al.
Transplantation Proceedings|February 1, 1989
Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantationG Elfenbein, J Krischer, R Babington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group studyV M Whitehead, M L Bernstein, R Vega, et al.
Cancer|July 15, 1984
Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group studyJ Krischer, V J Land, C I Civin, et al.
Investigational New Drugs|December 1, 1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C)C P Steuber, V J Land, C I Civin, et al.
Investigational New Drugs|July 1, 1992
Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group)R Nitschke, C Pratt, M Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Early diagnosis and specific treatment of insulin-dependent diabetesN Maclaren, A Muir, J Silverstein, et al.
The Journal of Clinical Investigation|February 1, 1995
Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcriptionA Muir, A Peck, M Clare-Salzler, et al.
Dermatology (Basel, Switzerland)|September 25, 2013
Pruritic acquired nevus of OtaS Quenan, V Strueven, N Saxer, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Seminars in Hematology|July 1, 1992
Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulinJ Krischer, G Elfenbein, R Babington, et al.
Transplantation Proceedings|February 1, 1989
Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantationG Elfenbein, J Krischer, R Babington, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group studyV M Whitehead, M L Bernstein, R Vega, et al.
Cancer|July 15, 1984
Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group studyJ Krischer, V J Land, C I Civin, et al.
Investigational New Drugs|December 1, 1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C)C P Steuber, V J Land, C I Civin, et al.
Investigational New Drugs|July 1, 1992
Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group)R Nitschke, C Pratt, M Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Early diagnosis and specific treatment of insulin-dependent diabetesN Maclaren, A Muir, J Silverstein, et al.
The Journal of Clinical Investigation|February 1, 1995
Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcriptionA Muir, A Peck, M Clare-Salzler, et al.
Dermatology (Basel, Switzerland)|September 25, 2013
Pruritic acquired nevus of OtaS Quenan, V Strueven, N Saxer, et al.
Pageof 8